Cargando…
Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response
BACKGROUND: Silicosis is an important occupational disease caused by inhalation of free silica and is characterized by persistent pulmonary inflammation, subsequent fibrosis and lung dysfunction. Until now, there has been no effective treatment for the disease due to the complexity of pathogenesis....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571334/ https://www.ncbi.nlm.nih.gov/pubmed/37828528 http://dx.doi.org/10.1186/s13020-023-00823-8 |
_version_ | 1785119966680317952 |
---|---|
author | Pu, Shuangshuang Yang, Zhifeng Zhang, Xiaofeng Li, Ming Han, Na Yang, Xiaohan He, Jin Yu, Gongchang Meng, Xiangjing Jia, Qiang Shao, Hua |
author_facet | Pu, Shuangshuang Yang, Zhifeng Zhang, Xiaofeng Li, Ming Han, Na Yang, Xiaohan He, Jin Yu, Gongchang Meng, Xiangjing Jia, Qiang Shao, Hua |
author_sort | Pu, Shuangshuang |
collection | PubMed |
description | BACKGROUND: Silicosis is an important occupational disease caused by inhalation of free silica and is characterized by persistent pulmonary inflammation, subsequent fibrosis and lung dysfunction. Until now, there has been no effective treatment for the disease due to the complexity of pathogenesis. Fermented cordyceps powder (FCP) has a similar effect to natural cordyceps in tonifying the lung and kidney. It has started to be used in the adjuvant treatment of silicosis. This work aimed to verify the protective effects of FCP against silicosis, and to explore the related mechanism. METHODS: Wistar rats were randomly divided into four groups including the saline-instilled group, the silica-exposed group, the silica + FCP (300 mg/kg) group and the silica + FCP (600 mg/kg) group. Silicosis rat models were constructed by intratracheal instillation of silica (50 mg). Rats in the FCP intervention groups received the corresponding dose of FCP daily by intragastric gavage. Rats were sacrificed on days 7, 28 and 56 after treatment, then samples were collected for further analysis. RESULTS: FCP intervention reduced the infiltration of inflammatory cells and the concentration of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1) at days 7, 28, 56, and decreased the expression of collagen, α-smooth muscle actin (α-SMA) and fibronectin (FN) at days 28 and 56 in the lung of silicosis rats. FCP also decreased the immune response of Th1 and Th17 at days 7, 28, 56 and inhibited the enhancement of the Th2 response at day 56. CONCLUSIONS: FCP intervention could alleviate silica-induced pulmonary inflammation and fibrosis, the protective effect may be achieved by reducing Th1 and Th17 immune responses and inhibiting the enhancement of the Th2 response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-023-00823-8. |
format | Online Article Text |
id | pubmed-10571334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105713342023-10-14 Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response Pu, Shuangshuang Yang, Zhifeng Zhang, Xiaofeng Li, Ming Han, Na Yang, Xiaohan He, Jin Yu, Gongchang Meng, Xiangjing Jia, Qiang Shao, Hua Chin Med Research BACKGROUND: Silicosis is an important occupational disease caused by inhalation of free silica and is characterized by persistent pulmonary inflammation, subsequent fibrosis and lung dysfunction. Until now, there has been no effective treatment for the disease due to the complexity of pathogenesis. Fermented cordyceps powder (FCP) has a similar effect to natural cordyceps in tonifying the lung and kidney. It has started to be used in the adjuvant treatment of silicosis. This work aimed to verify the protective effects of FCP against silicosis, and to explore the related mechanism. METHODS: Wistar rats were randomly divided into four groups including the saline-instilled group, the silica-exposed group, the silica + FCP (300 mg/kg) group and the silica + FCP (600 mg/kg) group. Silicosis rat models were constructed by intratracheal instillation of silica (50 mg). Rats in the FCP intervention groups received the corresponding dose of FCP daily by intragastric gavage. Rats were sacrificed on days 7, 28 and 56 after treatment, then samples were collected for further analysis. RESULTS: FCP intervention reduced the infiltration of inflammatory cells and the concentration of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1) at days 7, 28, 56, and decreased the expression of collagen, α-smooth muscle actin (α-SMA) and fibronectin (FN) at days 28 and 56 in the lung of silicosis rats. FCP also decreased the immune response of Th1 and Th17 at days 7, 28, 56 and inhibited the enhancement of the Th2 response at day 56. CONCLUSIONS: FCP intervention could alleviate silica-induced pulmonary inflammation and fibrosis, the protective effect may be achieved by reducing Th1 and Th17 immune responses and inhibiting the enhancement of the Th2 response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-023-00823-8. BioMed Central 2023-10-12 /pmc/articles/PMC10571334/ /pubmed/37828528 http://dx.doi.org/10.1186/s13020-023-00823-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Pu, Shuangshuang Yang, Zhifeng Zhang, Xiaofeng Li, Ming Han, Na Yang, Xiaohan He, Jin Yu, Gongchang Meng, Xiangjing Jia, Qiang Shao, Hua Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response |
title | Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response |
title_full | Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response |
title_fullStr | Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response |
title_full_unstemmed | Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response |
title_short | Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response |
title_sort | fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the th immune response |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571334/ https://www.ncbi.nlm.nih.gov/pubmed/37828528 http://dx.doi.org/10.1186/s13020-023-00823-8 |
work_keys_str_mv | AT pushuangshuang fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT yangzhifeng fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT zhangxiaofeng fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT liming fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT hanna fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT yangxiaohan fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT hejin fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT yugongchang fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT mengxiangjing fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT jiaqiang fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse AT shaohua fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse |